Interleukin 6, but not T helper 2 cytokines, promotes lung carcinogenesis.
about
Application of biclustering of gene expression data and gene set enrichment analysis methods to identify potentially disease causing nanomaterialsTumor necrosis factor links chronic obstructive pulmonary disease and K-ras mutant lung cancer through induction of an immunosuppressive pro-tumor microenvironmentLoss of p53 attenuates the contribution of IL-6 deletion on suppressed tumor progression and extended survival in Kras-driven murine lung cancerIDO is a nodal pathogenic driver of lung cancer and metastasis development.Nontypeable Haemophilus influenzae in chronic obstructive pulmonary disease and lung cancer.The BATTLE to personalize lung cancer prevention through reverse migration.Enhancement of lung tumorigenesis in a Gprc5a Knockout mouse by chronic extrinsic airway inflammation.Inflammation in chronic obstructive pulmonary disease and its role in cardiovascular disease and lung cancer.Cellular and molecular immunology of lung cancer: therapeutic implications.Radon Exposure, IL-6 Promoter Variants, and Lung Squamous Cell Carcinoma in Former Uranium MinersDisease-specific dynamic biomarkers selected by integrating inflammatory mediators with clinical informatics in ARDS patients with severe pneumonia.IL6 Blockade Reprograms the Lung Tumor Microenvironment to Limit the Development and Progression of K-ras-Mutant Lung Cancer.Promoting effect of neutrophils on lung tumorigenesis is mediated by CXCR2 and neutrophil elastase.The role of inflammation in the pathogenesis of lung cancer.Intracellular signals of lung cancer cells as possible therapeutic targets.Interleukin-6 -634C/G polymorphism is associated with lung cancer risk: a meta-analysis.Targeting roles of inflammatory microenvironment in lung cancer and metastasis.STK11/LKB1 Deficiency Promotes Neutrophil Recruitment and Proinflammatory Cytokine Production to Suppress T-cell Activity in the Lung Tumor Microenvironment.Identification of serum inflammatory markers as classifiers of lung cancer mortality for stage I adenocarcinoma.Novel function of Oncostatin M as a potent tumour-promoting agent in lung.Aqueous extracts of Ocimum grasstimum inhibits lipopolysaccharide-induced interleukin-6 and interleukin-8 expression in airway epithelial cell BEAS-2B.Application of bi-clustering of gene expression data and gene set enrichment analysis methods to identify potentially disease causing nanomaterials.Reduced IL-6 levels and tumor-associated phospho-STAT3 are associated with reduced tumor development in a mouse model of lung cancer chemoprevention with myo-inositol.Interleukin-6 neutralization alleviates pulmonary inflammation in mice exposed to cigarette smoke and poly(I:C).Identifying genes as potential prognostic indicators in patients with serous ovarian cancer resistant to carboplatin using integrated bioinformatics analysis.IL-6 family cytokines: Key inflammatory mediators as biomarkers and potential therapeutic targets.COPD-Type lung inflammation promotes K-ras mutant lung cancer through epithelial HIF-1α mediated tumor angiogenesis and proliferation
P2860
Q28385494-F26FAD1D-C659-42B7-A386-6FAA05C80A1DQ28392873-BD1DBD61-A64B-4B23-A1CC-A76DD5D3A89BQ28535183-5BBD0551-4124-4E41-B2E0-8AF546B566AAQ34289698-8C0D5141-6EFE-4D0B-96E5-697865BB26AFQ34621087-A6CC6780-2787-4D2E-9A4B-EA2380BB1F04Q35208501-AD942B35-1260-4BAF-B66D-3381A2356BFEQ35763410-0D96BB9E-CBF7-4D26-A44D-5110004AC2A5Q35897669-894E4673-4310-4382-94CE-FF2CF3BADD56Q36130505-A56DF1A9-9185-4812-B085-5F5BB17658C7Q36793506-6A19927C-E109-41BD-9003-77455D1554F4Q36940879-B4FAB229-B2AE-45EC-A2B1-66406050EB6CQ36963605-04CB1931-6FA5-407F-8F4E-8889A8B5C93DQ37582405-09D095FD-95A2-471E-B44C-802C5271A631Q37900640-CB5FEA84-B191-4F41-B66E-5CCFDC847027Q38364439-FBE4A6E6-7208-4B67-B294-CC18EEF124CEQ38401286-AE8FEE81-C0E6-4FF6-AA62-5191EBBCA91BQ38522515-E359CF8D-8D27-4854-BAC2-227BDD70DA7AQ38731119-51530D31-C49F-430B-8E1D-3F56F004D7ADQ38840370-EED45E90-7DEB-48F9-B3B6-61D444A1A225Q38979862-2E77369B-AE5F-4573-9B9F-71B1047937E1Q46491477-19AC949A-7613-49F8-8F47-7DA2136B5B1BQ46743685-B5BB22FC-F964-445F-AE10-C4088A4BA967Q47565249-1358DFC9-0D4F-4250-BA05-15093133A2D9Q50934926-C7783534-95FD-443F-A1F3-A6C304F68FD8Q52310220-B2BA6FC6-C7FB-4542-85AC-A23C79328DA7Q52560420-ED4228F7-CC1A-4D14-AFA4-94EF87430812Q58779415-E7F6FC96-E7F3-4602-A477-8F0D34D8B3B7
P2860
Interleukin 6, but not T helper 2 cytokines, promotes lung carcinogenesis.
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Interleukin 6, but not T helper 2 cytokines, promotes lung carcinogenesis.
@ast
Interleukin 6, but not T helper 2 cytokines, promotes lung carcinogenesis.
@en
Interleukin 6, but not T helper 2 cytokines, promotes lung carcinogenesis.
@nl
type
label
Interleukin 6, but not T helper 2 cytokines, promotes lung carcinogenesis.
@ast
Interleukin 6, but not T helper 2 cytokines, promotes lung carcinogenesis.
@en
Interleukin 6, but not T helper 2 cytokines, promotes lung carcinogenesis.
@nl
prefLabel
Interleukin 6, but not T helper 2 cytokines, promotes lung carcinogenesis.
@ast
Interleukin 6, but not T helper 2 cytokines, promotes lung carcinogenesis.
@en
Interleukin 6, but not T helper 2 cytokines, promotes lung carcinogenesis.
@nl
P2093
P2860
P1476
Interleukin 6, but not T helper 2 cytokines, promotes lung carcinogenesis
@en
P2093
Cesar E Ochoa
Christopher M Evans
Mihai Gagea
Scott E Evans
Seyed Javad Moghaddam
Seyedeh Golsar Mirabolfathinejad
Venado Ana Ruiz
P2860
P356
10.1158/1940-6207.CAPR-10-0180
P577
2010-11-22T00:00:00Z